140 results
Page 5 of 7
8-K
EX-99.1
cip16pyn6f25xe6u
23 Feb 21
Biocardia Signs Agreement with Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates
8:00am
8-K
EX-99.1
6isws omq
17 Feb 21
Biocardia Announces Clinical Leadership Changes
8:30am
8-K
EX-99.1
j2uohcooe1p 0wm
2 Feb 21
BioCardia Update on Cell Therapy Product Development and 2021 Milestones
8:30am
8-K
EX-99.1
qk5k80 43kf4b
11 Jan 21
Accomplished Biotech Executive Krisztina Zsebo, PH.D. Joins Biocardia’s Board of Directors
8:31am
8-K/A
EX-99.1
7t4 l4ooung7i9jbq0yf
21 Dec 20
Biocardia, Inc. Announces $10.5 Million
5:28pm
8-K
EX-99.1
w5lpy3 oj6sjkn9k
17 Dec 20
Biocardia Announces Positive DSMB Futility Analysis Review and Recommendation to Continue Phase Iii
8:30am
424B5
daiczc 699
16 Dec 20
Prospectus supplement for primary offering
6:08am
8-K
EX-99.1
zvmj8zsxeu9wus
16 Dec 20
Biocardia, Inc. Announces $8.5 Million
6:02am
8-K
EX-99.1
f1vm5a
15 Dec 20
Biocardia, Inc. Announces $8.5 Million
4:08pm
424B5
qn5bv
15 Dec 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
n0p4e 2va6
1 Dec 20
Regulation FD Disclosure
8:00am
8-K
EX-99.1
i1cio
27 Oct 20
Paper published in the “International Journal of Cardiology” demonstrates safety and tolerability while showing functional improvement at six months
7:30am
8-K
EX-99.1
1isb6j6vmpoengyxdjje
13 Aug 20
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
6:11am
8-K
EX-99.1
nxb6nan4ro4c75v0h01
19 Jun 20
Biocardia Announces Pricing of $10 Million Public Offering
5:09pm
424B4
cq8iv1pi1408il0o9y
18 Jun 20
Prospectus supplement with pricing info
7:59am